Serotonin News and Research

Latest Serotonin News and Research

Reviva Pharmaceuticals completes enrollment in RP5063 phase 2 trial for schizophrenia

Reviva Pharmaceuticals, Inc., a privately held drug discovery and development company, today announces completion of patient enrollment in the phase 2 clinical trial of RP5063 for the treatment of schizophrenia and schizoaffective disorder.

16 Jan 2013

Fluoxetine stimulates production of new neurons from L1-INP cells

The production of new neurons in the adult normal cortex in response to the antidepressant, fluoxetine, is reported in a study published online this week in Neuropsychopharmacology.

7 Jan 2013

Link between SSRI use in pregnancy and stillbirth refuted

Study findings suggest that use of selective serotonin reuptake inhibitors during pregnancy does not pose any increased infant mortality risk.

3 Jan 2013

No significant link between SSRI use during pregnancy and risk of stillbirth, neonatal death

In a study that included nearly 30,000 women from Nordic countries who had filled a selective serotonin reuptake inhibitor (SSRI) prescription during pregnancy, researchers found no significant association between use of these medications during pregnancy and risk of stillbirth, neonatal death, or postneonatal death, after accounting for factors including maternal psychiatric disease, according to a study in the January 2 issue of JAMA.

1 Jan 2013

GI bacteria exert some control over their hosts' appetites: Review

Over the last half decade, it has become increasingly clear that the normal gastrointestinal (GI) bacteria play a variety of very important roles in the biology of human and animals. Now Vic Norris of the University of Rouen, France, and coauthors propose yet another role for GI bacteria: that they exert some control over their hosts' appetites.

20 Dec 2012

Bullying among children may be a threat to their future mental health

A recent study by a researcher at the Centre for Studies on Human Stress (CSHS) at the H-pital Louis-H. Lafontaine and professor at the Universit- de Montr-al suggests that bullying by peers changes the structure surrounding a gene involved in regulating mood, making victims more vulnerable to mental health problems as they age.

18 Dec 2012

Glutamate linked to suicidal behavior

Researchers have found the first proof that a chemical in the brain called glutamate is linked to suicidal behavior, offering new hope for efforts to prevent people from taking their own lives.

15 Dec 2012

AZD6765 briefly improves treatment-resistant patients' depression symptoms in minutes

A drug that works through the same brain mechanism as the fast-acting antidepressant ketamine briefly improved treatment-resistant patients' depression symptoms in minutes, with minimal untoward side effects, in a clinical trial conducted by the National Institutes of Health. The experimental agent, called AZD6765, acts through the brain's glutamate chemical messenger system.

13 Dec 2012

Takeda, Lundbeck announce FDA acceptance of vortioxetine NDA submission

Takeda Global Research & Development Center, Inc., (Takeda) and H. Lundbeck A/S (Lundbeck) jointly announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing their submission of a New Drug Application (NDA) for vortioxetine for the treatment of major depressive disorder (MDD) in adult patients.

13 Dec 2012

Drugs that bind to specific serotonin receptors can improve and impair female sexual function

Drugs that bind to specific serotonin receptors in the brain can both improve and impair female sexual function in non-human primates.

12 Dec 2012

Study examines association between ischemic-hypoxic conditions and ADHD

Children who had in-utero exposure to ischemic-hypoxic conditions, situations during which the brain is deprived of oxygen, were significantly more likely to develop attention deficit hyperactivity disorder later in life as compared to unexposed children, according to a Kaiser Permanente study published in the journal Pediatrics.

10 Dec 2012

Highlights for December 2012 issue of GSA’s Genetics journal

Listed below are the selected highlights for the December 2012 issue of the Genetics Society of America's journal, Genetics.

5 Dec 2012

Cognitive behavioral therapy for anxiety-related dizziness

Patients with chronic subjective dizziness that is related to anxiety may substantially benefit from a short course of cognitive behavioral therapy, report researchers.

4 Dec 2012

Antidepressants in normal dosage may positively impact mood and seizure frequency

Epilepsy and depression are common co-morbidities. Concern for the potential of certain antidepressants to induce seizures has led to under-treating depression and anxiety disorders in epilepsy patients. Research presented today at the 66th American Epilepsy Society meeting suggests that antidepressants in normal dosage may have a positive impact on both mood and seizure frequency.

4 Dec 2012

Certain SSRI medications fail to achieve same selectivity for prevention of SUDEP

Scientists from Southern Illinois University today reported the results of a study evaluating the potential effect of two selective serotonin reuptake inhibitors (SSRI) antidepressant medications in reducing the risk of sudden unexpected death in epilepsy (SUDEP).

4 Dec 2012

LP-211 compound shows promise against Fragile X syndrome

A potential new therapeutic strategy for treating Fragile X syndrome is detailed in a new report appearing in the current issue of Biological Psychiatry, from researchers led by Dr. Lucia Ciranna at University of Catania in Italy.

29 Nov 2012

Omega-3 fatty acids can benefit women at risk of postpartum depression

The "feel-good" hormone serotonin, depleted by pregnancy, can be replenished by adding sources of omega-3 to the diets of pregnant women and new mothers - a development particularly beneficial to the 10 to 15 percent of women at risk for postpartum depression, according to a recent University of Montreal study published in the latest edition of the Canadian Journal of Psychiatry.

29 Nov 2012

Low levels of omega-3 may be behind postpartum depression

Low levels of omega-3 may be behind postpartum depression, according to a review lead by Gabriel Shapiro of the University of Montreal and the Research Centre at the Sainte-Justine Mother and Child Hospital.

16 Nov 2012

Aggression a trait in bipolar II disorder

Results from a Taiwanese study suggest that aggression may be a trait marker for bipolar II disorder.

14 Nov 2012

Degeneration of serotonergic neurons linked to spasticity in ALS

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease with an occurrence rate in France similar to multiple sclerosis (two to three new cases per year for every 100,000 residents). It has a specific affect on neurons responsible for motor control, in particular motor neurones and central motor neurones. The former, located in the spinal cord, are directly linked to muscles and are used for muscle contraction and stretching.

7 Nov 2012

Serotonin News and Research

Latest Serotonin News and Research

Reviva Pharmaceuticals completes enrollment in RP5063 phase 2 trial for schizophrenia

Fluoxetine stimulates production of new neurons from L1-INP cells

Link between SSRI use in pregnancy and stillbirth refuted

No significant link between SSRI use during pregnancy and risk of stillbirth, neonatal death

GI bacteria exert some control over their hosts' appetites: Review

Bullying among children may be a threat to their future mental health

Glutamate linked to suicidal behavior

AZD6765 briefly improves treatment-resistant patients' depression symptoms in minutes

Takeda, Lundbeck announce FDA acceptance of vortioxetine NDA submission

Drugs that bind to specific serotonin receptors can improve and impair female sexual function

Study examines association between ischemic-hypoxic conditions and ADHD

Highlights for December 2012 issue of GSA’s Genetics journal

Cognitive behavioral therapy for anxiety-related dizziness

Antidepressants in normal dosage may positively impact mood and seizure frequency

Certain SSRI medications fail to achieve same selectivity for prevention of SUDEP

LP-211 compound shows promise against Fragile X syndrome

Omega-3 fatty acids can benefit women at risk of postpartum depression

Low levels of omega-3 may be behind postpartum depression

Aggression a trait in bipolar II disorder

Degeneration of serotonergic neurons linked to spasticity in ALS

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Serotonin News and Research

Latest Serotonin News and Research

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Empowering genomics research with cloud-based innovation

Newsletters you may be interested in